Investor Area

Home / Investor Area / News / Appendix 4E and Preliminary Financial Report
 

Appendix 4E and Preliminary Financial Report

 

CLINUVEL PHARMACEUTICALS LTD (CLINUVEL), a global biopharmaceutical company focused on developing and delivering treatments for patients with a range of severe genetic and skin disorders, today announced its Appendix 4E and Preliminary Financial Report for the year ending 30 June 2019. […]

Download PDF